Main Menu

NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

ARCA biopharma Inc (NASDAQ: ABIO)

 
ABIO Technical Analysis
1.5
As on 9th Jun 2023 ABIO SHARE Price closed @ 2.06 and we RECOMMEND Sell for LONG-TERM with Stoploss of 2.23 & Buy for SHORT-TERM with Stoploss of 2.03 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

ABIOSHARE Price

Open 2.07 Change Price %
High 2.10 1 Day -0.01 -0.48
Low 2.04 1 Week -0.05 -2.37
Close 2.06 1 Month 0.07 3.52
Volume 18113 1 Year -0.27 -11.59
52 Week High 2.55 | 52 Week Low 1.77
 
NASDAQ USA Most Active Stocks
TSLA 244.40 4.06%
TTOO 0.07 -12.50%
SOFI 8.18 0.74%
FFIE 0.33 6.45%
PONO 1.72 2.38%
AMD 124.92 3.20%
IDEX 0.06 0.00%
NKLA 0.70 14.75%
AMZN 123.43 -0.66%
AAPL 180.96 0.22%
 
NASDAQ USA Top Gainers Stocks
IDRA 8.64 1909.30%
REDU 3.41 1075.86%
CTXRW 0.14 600.00%
NDRAW 0.03 200.00%
METXW 0.05 150.00%
GLSPT 33.43 138.62%
BCAC 22.71 125.30%
JCIC 22.08 116.68%
AURCW 0.04 100.00%
NOVVW 0.02 100.00%
 
NASDAQ USA Top Losers Stocks
OTIC 0.01 -91.67%
PTRAW 0.23 -89.59%
PTIXW 0.01 -66.67%
AGBAW 0.02 -66.67%
MLACW 0.02 -60.00%
MILEW 0.06 -53.85%
RCRTW 0.02 -50.00%
LOTZW 0.01 -50.00%
GSMGW 0.01 -50.00%
DKDCW 0.01 -50.00%
 
 
ABIO
Daily Charts		 ABIO
Intraday Charts		 Whats New @
Bazaartrend		 ABIO
Free Analysis
 
ABIO Important Levels Intraday
RESISTANCE2.18
RESISTANCE2.14
RESISTANCE2.12
RESISTANCE2.09
SUPPORT2.03
SUPPORT2.00
SUPPORT1.98
SUPPORT1.94
 
ABIO Forecast April 2024
Share
4th UP Forecast2.89
3rd UP Forecast2.62
2nd UP Forecast2.46
1st UP Forecast2.29
1st DOWN Forecast1.83
2nd DOWN Forecast1.66
3rd DOWN Forecast1.5
4th DOWN Forecast1.23
 
ABIO Weekly Forecast
4th UP Forecast2.64
3rd UP Forecast2.45
2nd UP Forecast2.34
1st UP Forecast2.22
1st DOWN Forecast1.90
2nd DOWN Forecast1.78
3rd DOWN Forecast1.67
4th DOWN Forecast1.48
 
ABIO Forecast2024
4th UP Forecast3.97
3rd UP Forecast3.36
2nd UP Forecast2.98
1st UP Forecast2.6
1st DOWN Forecast1.52
2nd DOWN Forecast1.14
3rd DOWN Forecast0.76
4th DOWN Forecast0.15
 
 
ABIO Other Details
Segment EQ
Market Capital 37754460.00
Sector Healthcare
Industry Biotechnology
Offical website >
 
ABIO Address
ABIO
 
ABIO Latest News
 
Your Comments and Response on ARCA biopharma Inc
 
ABIO Business Profile
ARCA biopharma, Inc., a clinical-stage biopharmaceutical company, develops and commercializes genetically targeted therapies for cardiovascular diseases. Its lead product candidates are Recombinant Nematode Anticoagulant Protein c2 (rNAPc2) (AB201), which is in Phase 2 clinical trial for the treatment of diseases caused by ribonucleic acid viruses initially focusing on COVID-19; and Gencaro (bucindolol hydrochloride), a pharmacogenetically-targeted beta-adrenergic receptor antagonist that has completed Phase 2 trial for the treatment of atrial fibrillation in patients with chronic heart failure (HF). The company also engages in the development of AB171, a thiol-containing derivative isosorbide mononitrate for the treatment of HF and peripheral arterial disease. ARCA biopharma, Inc. is headquartered in Westminster, Colorado. Address: 10170 Church Ranch Way, Westminster, CO, United States, 80021
 
© 2005-2023 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service